DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

4.15 0.03 (0.73%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARNA $4.15 0.73%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.19
Previous Close $4.12
Daily Range $4.10 - $4.24
52-Week Range $4.05 - $7.97
Market Cap $912.3M
P/E Ratio -15.85
Dividend (Yield) $0.00 (0.0%)
Volume 5,715,194
Average Daily Volume 4,349,523
Current FY EPS -$0.35

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary Rss Feed

3 Simple Ways to Invest Like George Soros

George Soros is one of the most successful investors of all time. Here are three easy ways to follow in his footsteps.

Belviq Sales Crack Critical Level

Advertising And The Belviq Re-Launch

Belviq Sales Rise 2%

Biotech Investing: 3 Ways You're Doing It Wrong

Biotech investing might appear easy considering some of the big gains we've witnessed in recent years, but these three common mistakes make it very difficult for the average biotech investor to make money.

Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind

MannKind Corp. And The Folly Of Cult Biotech Stocks

Arena And VIVUS: A Case Study In Small-Cap Pharma

Belviq Sales Flatten Out But Edge Above Qsymia

FDA Data: Good News For One Anti-Obesity Company, Not So Good For Another

See More ARNA News...

ARNA's Top Competitors

ARNA $4.15 (0.73%)
Current stock: ARNA
AMGN $137.96 (-1.02%)
Current stock: AMGN
GILD $109.36 (1.67%)
Current stock: GILD
BIIB $342.68 (-0.10%)
Current stock: BIIB